About Cubresa
Cubresa is a company based in Winnipeg (Canada) founded in 2011. Cubresa has raised $4.5 million across 3 funding rounds from investors including Manitoba Technology Accelerator. Cubresa offers products and services including BrainPET, NuPET, and NuPET Bio. Cubresa operates in a competitive market with competitors including Mercurius Health, Niowave, Mediso, Clear Vascular and PETsys Electronics, among others.
- Headquarter Winnipeg, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cubresa Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.5 M (USD)
in 3 rounds
-
Latest Funding Round
$3.5 M (USD), Series A
Dec 22, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cubresa
Cubresa offers a comprehensive portfolio of products and services, including BrainPET, NuPET, and NuPET Bio.
PET insert for MRI scanners used in human brain research.
Portable PET system for animal studies and research applications.
Specialized PET scanner for infectious disease research in labs.
Funding Insights of Cubresa
Cubresa has successfully raised a total of $4.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cubresa
Cubresa has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Manitoba Technology Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Cubresa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cubresa
Investment portfolio details for Cubresa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cubresa
Detailed financials for Cubresa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cubresa Comparisons
Peer comparison for Cubresa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cubresa
Cubresa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mercurius Health, Niowave, Mediso, Clear Vascular and PETsys Electronics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Resources and training for radiotherapy and nuclear medicine are provided.
|
|
| Locked | Locked | Locked |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| Locked | Locked | Locked |
Nuclear medicine and hybrid imaging equipment
|
|
| Locked | Locked | Locked |
Develops pharmaceutical products for treating cardiovascular conditions.
|
|
| Locked | Locked | Locked |
Gamma ray detectors are developed for medical PET scanners.
|
Detailed competitors of Cubresa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cubresa
Complete news archive for Cubresa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cubresa
Cubresa was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Cubresa is headquartered in Winnipeg, Canada. It is registered at Winnipeg, Manitoba, Canada.
Cubresa is a funded company, having raised a total of $4.5M across 3 funding rounds to date.
Cubresa was founded in 2011 in Winnipeg, Canada, within the nuclear imaging sector. Preclinical PET and SPECT scanners are developed and manufactured to enable non-invasive visualization of molecular biochemical processes. The portfolio includes Compact SPECT scanners and NuPET in-bore PET systems that integrate with existing MRI instruments for hybrid imaging platforms. SensL SPM chips are incorporated for reliable operation and performance.
Cubresa's top competitors include Niowave, Mediso and Mercurius Health.
Cubresa offers BrainPET, NuPET, and NuPET Bio.
Cubresa has 1 investor. Key investors include Manitoba Technology Accelerator.